Boehringer Ingelheim Vetmedica Inc. is seeking research proposals focusing on Pigeon Fever for its 2012 Equine Research Awards, the St. Joseph, Mo.-based company reported today.
BIVI will select three proposals and award $25,000 to each to fund research on Pigeon Fever, the infection caused by Corynebacterium pseudotuberculosis bacteria.
Proposals must address one or more of the following subjects:
• Pathophysiology of C. pseudotuberculosis and development of an equine challenge model;
• Virulence factors and strain differences among isolates of C. pseudotuberculosis isolated from internal and external infections and different geographic locations.
• Increased incidence and spread to different geographic locations and association with climate change;
• Comparison of host immunity between infections resulting in internal infection and recurrent infection in recovered horses.
• Seasonality of infection with C. pseudotuberculosis and studies of insect vectors.
The contest is open to researchers from the United States and Canada. The deadline for submission is Sept. 1, 2012.
An equine research review board will select winning proposals based on their potential impact on the equine industry, originality, scientific quality and probability of success in completing the yearlong studies. The awards will be announced during the 2012 America Association of Equine Practitioners Annual Convention in Anaheim, Calif., in December.
BIVI launched the Equine Research Awards in 2011 to support veterinary research that results in practical applications or insights into important equine disease and that improves the quality of life for all horses, the company said. Last year’s awards focused on Equine Rhinitis Virus.
Submission instructions can be found at www.equinediseaseresearch.com.